MapLight Therapeutics, Inc. (MPLT) Form 10-Q Quarterly Reports
MapLight Therapeutics, Inc. (MPLT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MPLT
CIK: 1770069
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RSM US LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerKaitlin Folinus
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | 4 Filing | 0002021238-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | 4 Filing | 0001709954-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | 4 Filing | 0001728746-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | 4 Filing | 0001789970-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | 4 Filing | 0002021233-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | 4 Filing | 0001658918-26-000018 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001974158-26-000108 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001974158-26-000107 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001974158-26-000106 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001974158-26-000105 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001974158-26-000104 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010262 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001193125-26-422882 | View SEC Doc Filr Page |
| EFFECT | 2026-09-23 | — | EFFECT Filing | 9999999995-26-003044 | View SEC Doc Filr Page |
| 424B3 | 2026-09-23 | — | 424B3 | 0001193125-26-399452 | View SEC Doc Filr Page |
| S-1/A | 2026-09-18 | — | S-1/A | 0001193125-26-395559 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | 4 Filing | 0001789970-26-000016 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001974158-26-000102 | View SEC Doc Filr Page |
| S-1 | 2026-09-09 | — | S-1 | 0001193125-26-386648 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-20 | — | SCHEDULE 13G Filing | 0001012975-26-000807 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0002021238-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001709954-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001728746-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001789970-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0002021233-26-000014 | View SEC Doc Filr Page |